During the past decade, Hall-Garcia Cardiology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hall-Garcia Cardiology Associates" #1 collaborator was "Medtronic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hall-Garcia Cardiology Associates" are "Heart Failure" (2 trials), "Ventricular Dysfunction" (2 trials), "Atrial Flutter" (1 trials), "Bradycardia" (1 trials) and "Heart Failure, Congestive" (1 trials). Many other conditions were trialed in "Hall-Garcia Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Hall-Garcia Cardiology Associates" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "ACUITY Spiral Left Ventricular Lead" (1 trials), "Blazer® Open-Irrigated Ablation Catheter" (1 trials), "Control Catheter" (1 trials), "ICD/ CRT-D" (1 trials) and "Protecta DR-ICD or CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hall-Garcia Cardiology Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hall-Garcia Cardiology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hall-Garcia Cardiology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hall-Garcia Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".